Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 344, pseudogene (RN7SL344P)

Target
RN7SL344P
Molecular classification
Pseudogene, Non-coding RNA-derived element, Retrotransposed copy (pseudogene subtype)
01

Overview

RN7SL344P is a pseudogene derived from the human 7SL RNA, a critical component of the signal recognition particle responsible for protein targeting to cellular membranes[3][5][7]. The human genome contains hundreds of 7SL-related pseudogenes likely resulting from reverse transcription and genomic integration of the original 7SL RNA sequence[5][7]. These are generally truncated and non-functional, lacking conserved promoter elements and typically not expressed as functional RNAs or proteins. Although some pseudogenes elsewhere in the genome can exert regulatory functions—such as acting as molecular sponges for microRNAs or modulating gene expression—there is currently no evidence for any specific biological or disease relevance for RN7SL344P. It is not considered a receptor, enzyme, or any form of classical drug-targetable molecule[2][3][5][7].

Other names
RN7SL344PRNA, 7SL, cytoplasmic 344, pseudogene7SL pseudogene (generic; used for other loci)
02

Mechanism of action

Not applicable.

03

Biological functions

None currently attributed directly to RN7SL344P.May act as regulatory RNA elements, sponges for microRNAs, or as decoys for transcription factors, but this is not established for this specific locus.
04

Disease associations

None established for RN7SL344P.General pseudogene polymorphisms may be associated with diseases elsewhere in the genome, but direct connections are rare and unproven for this locus.

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 344, pseudogene (RN7SL344P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 344, pseudogene (RN7SL344P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call